Armata Pharmaceuticals, Inc. Share Price
ARMPArmata Pharmaceuticals, Inc. Stock Performance
Open $8.06 | Prev. Close $7.88 | Circuit Range N/A |
Day Range $7.84 - $8.06 | Year Range $0.91 - $16.34 | Volume 1,856 |
Average Traded $7.90 |
Armata Pharmaceuticals, Inc. Share Price Chart
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $8.06 | $7.89 | -1.00% |
05-Feb-26 | $7.75 | $7.97 | -1.36% |
04-Feb-26 | $8.03 | $8.08 | +5.07% |
03-Feb-26 | $7.21 | $7.69 | +2.53% |
02-Feb-26 | $7.04 | $7.50 | +10.29% |
30-Jan-26 | $6.67 | $6.80 | +3.11% |
29-Jan-26 | $6.63 | $6.59 | +0.92% |